Robert Löfberg
Karolinska Institutet · 200 works · 11,581 citations · h-index 57
Top works
- A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
- Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
- A Comparison of Budesonide with Prednisolone for Active Crohn's Disease
- Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?
- Family history as a risk factor for colorectal cancer in inflammatory bowel disease
- Primary sclerosing cholangitis in ulcerative colitis—A risk factor for the development of dysplasia and DNA aneuploidy?
- The Risk of Colorectal Cancer in Ulcerative Colitis: An Epidemiologic Study
- Incidence of Crohn’s disease in Stockholm County 1955–1989
- Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients
- Colonoscopic surveillance in long-standing total ulcerative colitis—A 15-year follow-up study
- Pouchitis following pelvic pouch operation for ulcerative colitis
- Increased Risk of Cancer in Ulcerative Colitis: A Population-Based Cohort Study
- Microscopic colitis syndrome.
- MUTATION SCREENING IN THE CD19 AND CD43 (SIALOPHORIN) GENES IN CROHN DISEASE PATIENTS
- A Controlled Randomized Trial of Budesonide versus Prednisolone Retention Enemas in Active Distal Ulcerative Colitis
- Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis
- Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study
- Oral budesonide for prevention of postsurgical recurrence in Crohn's disease
- Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.